Skip to: Content
Skip to: Site Navigation
Skip to: Search

November 22, 2008 10:29:12 CST

Learn about Newser Points »

« Back to the grid | Next story »

Americans Go Abroad, Online for New Diet Pill

Posted Jun 11, 07 8:21 PM CDT in US,  Science & Health,  Glossies 

(Newser) – The weight loss drug Acomplia is stuck in FDA limbo, but that isn't stopping Americans from ordering it off the Internet or buying it in Europe, where it's legal. If the government rules that its lowering of weight and cholesterol balances out the possible side effects, including suicide and depression, Acomplia could be worth billions to manufacturer Sanofi-Aventis.

Acomplia will be sold as Zimulti in the US, where one-third of the population is obese. The drug stifles hunger by blocking brain receptors and interacts directly with fat cells. The FDA was originally expected to rule on the drug last year, Bloomberg reports; safety questions have forced three postponements, and a decision is now expected next month.

Source Bloomberg

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon

Related Newser Stories

  • FDA Advisory Panel Rejects Weight-Loss Drug

    Jun 14, 07 6:41 CDT
    FDA Advisory Panel Rejects Weight-Loss Drug Accomplia, a weight-loss drug marketed in 18 other countries, failed to win approval from an FDA advisory board yesterday. The 14-member panel of outside experts ruled unanimously that manufacturer Sanofi-Aventis had not dispelled concerns about the safety of the drug, whose potential side effects include suicidal thoughts, anxiety, and depression. More »

  (Getty Images)
  (Getty Images)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (
1
 of 4)

Tags

medicine • FDA • suicide • depression • obesity epidemic • weight loss • cholesterol • diet pills • Sanofi Aventis • Acomplia


Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular

Loading...

Other Home Stories

What is Newser?

2008 Codie Finalist

Face it: there's too much news. At Newser a team of editors and writers culls the most important stories from hundreds of U.S. and international sources and reduces them to a headline, picture, and two paragraphs. It's the Newser guarantee: we can take any report or column or video and pack what you need to know into 120 words or less. Newser's short-form aggregation, visual format, and unique information tools help you get more of the kind of news you want, in a quicker and more entertaining way. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »